0000950123-22-002502.txt : 20220214 0000950123-22-002502.hdr.sgml : 20220214 20220214084043 ACCESSION NUMBER: 0000950123-22-002502 CONFORMED SUBMISSION TYPE: 13F-NT PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 EFFECTIVENESS DATE: 20220214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bain Capital Life Sciences Partners, LP CENTRAL INDEX KEY: 0001703030 IRS NUMBER: 981329585 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-NT SEC ACT: 1934 Act SEC FILE NUMBER: 028-18476 FILM NUMBER: 22625685 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6175162878 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 13F-NT 1 primary_doc.xml 13F-NT LIVE 0001703030 XXXXXXXX 12-31-2021 12-31-2021 false Bain Capital Life Sciences Partners, LP

200 Clarendon Street Boston MA 02116

13F NOTICE 028-18476 28-18477 Bain Capital Life Sciences Investors, LLC Y The report on Form 13F for the period ended December 31, 2021 for Bain Capital Life Sciences Partners, LP (the "Fund") is being filed by Bain Capital Life Sciences Investors, LLC, which is the general partner of the Fund. Adam Koppel 617-516-2000 /s/ Adam Koppel Boston MA 02-14-2022